EU AIF definition

EU AIF means EU AIF as defined in point (k) of Article 4(1) of Directive 2011/61/EU;
Sample 1Sample 2Sample 3
EU AIF means EU AIF as defined in Article 4(1)(k) of Directive 2011/61/EU; (4b) 'EU AIFM' means EU AIFM as defined in Article 4(1)(l) of Directive 2011/61/EU;
Sample 1Sample 2Sample 3
EU AIF means an AIF which:
Sample 1Sample 2

Examples of EU AIF in a sentence

  • The management company thus also pursues collective asset management for EU UCITS, EU AIF and foreign assets which are analogous to domestic invest- ment funds.

  • The AIFM shall submit a notification to the competent authorities of its home Member State in respect of each EU AIF that it intends to market.

  • Besides posing general questions on the competitiveness of the EU AIF market, this section seeks views on how the EU market could interact with international partners in the area governed by the AIFMD.

  • This section seeks to gather views on potential improvements to the AIFMD legal framework to facilitate further integration of the EU AIF market.

  • Where the EU AIF is a feeder AIF the right to market referred to in the first subparagraph is subject to the condition that the master AIF is also an EU AIF which is managed by an authorised EU AIFM.

  • Where the EU AIF is a feeder AIF the right to market referred to in the first subparagraph is subject to the condition that the master AIF is also an EU AIF and is managed by an authorised EU AIFM.

  • An ELTIF may acquire no more than 30 % of the units or shares of a single ELTIF, EuVECA, EuSEF, UCITS or of an EU AIF managed by an EU AIFM.

  • The AIFM shall continue providing investors who remain invested in the EU AIF with the information required under Articles 22 and 23.

  • An AIFM shall, for each of the EU AIF it manages and for each of the AIF it markets in the European Union, make available an annual report for each financial year no later than six months following the end of the financial year.

  • The following sections discuss the AIFMD’s effect on the EU AIF market.


More Definitions of EU AIF

EU AIF means either: (i) an AIF which is authorised or registered in an EEA member state under applicable national law; or (ii) an AIF which is not authorised or registered in an EEA member state, but has its registered office and/or head office in an EEA member state.
Sample 1
EU AIF means an alternative investment fund established in a Member State;
Sample 1
EU AIF means:
Sample 1
EU AIF means an AIF that is not an AIF referred to in the preceding paragraph and is authorised by or registered with the competent authority of a Member State, and an AIF that is not authorised or registered in a Member State and has its registered office or head office in that Member State.
Sample 1
EU AIF means either:
Sample 1
EU AIF means: (i) an AIF which is authorised or registered in a member state under the applicable national law; or (ii) an AIF which is not authorised or registered in a member state, but has its registered office and/or head office in a member state (Article 4(k) of the Directive).
Sample 1

Related to EU AIF

  • EU GDPR means Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC.

  • EUWA means the European Union (Withdrawal) Act 2018;

  • EUA or “Extended Use Agreement” means, with respect to the HC Program, an agreement which sets forth the set-aside requirements and other Development requirements under the HC Program.

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Major EU Country means one or more of the following countries within the European Union: France, Germany, Italy, Spain and the United Kingdom.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • EU means the European Union.

  • Europe means the European Union, the European Economic Area and/or their member states, Switzerland and the United Kingdom.

  • EUMA means the “SAP Delivered Support Agreement” which sets out the terms and conditions under which SAP provides support to End Users and which will be provided by SAP on a deal by deal basis.

  • HKMA means the Hong Kong Monetary Authority;

  • Licensed clinical social worker means an individual who meets the licensed clinical social worker requirements established in KRS 335.100.

  • EMEA means the European Agency for the Evaluation of Medicinal Products, or any successor agency thereto.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Approved clinical trial means a phase I, phase II, phase III, or phase IV clinical trial that is conducted in relation to the prevention, detection, or treatment of cancer or other life-threatening disease or Condition and is described in any of the following:

  • IRDAI means the Insurance Regulatory and Development Authority of India.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Digital Signal Level 0 (DS-0 means the lowest-level signal in the time division multiplex digital hierarchy, and represents a voice-grade channel operating at either the 56 Kbps or 64 Kbps transmission bit rates. There are twenty-four (24) DS-0 channels in a DS-1.

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Clinical review criteria means the written screening procedures, decision abstracts, clinical protocols, and practice guidelines used by a health carrier to determine the necessity and appropriateness of health care services.

  • MFDA means the Mutual Fund Dealers Association of Canada;

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • CM means City Manager of COE appointed in terms of Section 82 of the Local Government: Municipal Structures Act 117 of 1998

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Digital Signal Level 1 (DS-1 means the 1.544 Mbps first level signal in the time division multiplex hierarchy.

  • municipal spatial development framework means a municipal spatial development framework adopted by the Municipality in terms of Chapter 5 of the Municipal Systems Act;

  • Global Development Plan has the meaning set forth in Section 3.1.